The regulatory role of solute carrier family 12 members in tumor progression and immune responses has been rarely reported, and recent studies have found that SLC12A8 plays a critical role in bladder cancer progression and EMT (42). Here, SLC12A8 is linked to urinary bladder carcinoma.